跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.91) 您好!臺灣時間:2026/08/10 12:42
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:李建興
研究生(外文):Lee Jiahn-Shing
論文名稱:α-水晶體蛋白之分子保護作用:結構與功能的研究
論文名稱(外文):α-Crystallin Possessing Molecular Chaperone Activity: Structural and Functional Study
指導教授:邱式鴻邱式鴻引用關係魏正舒魏正舒引用關係
指導教授(外文):Chiou Shyh-HorngWei Jeng-Shu
學位類別:博士
校院名稱:長庚大學
系所名稱:臨床醫學研究所
學門:醫藥衛生學門
學類:醫學學類
論文種類:學術論文
論文出版年:1998
畢業學年度:86
語文別:中文
論文頁數:96
中文關鍵詞:α-水晶體蛋白分子保護立體構形與功能白內障選殖與表現蛋白質凝集轉譯後修飾表面厭水性
外文關鍵詞:α-CrystallinMolecular ChaperoneConformation and FunctionCataractCloning and ExpressionProtein AggregationPost-translational ModificationSurface Hydrophobicity
相關次數:
  • 被引用被引用:0
  • 點閱點閱:451
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
摘要︰

最近α-水晶體蛋白被歸類為小熱休克蛋白家族的一員,在1992年Joseph Horwitz更證明它具有分子保護作用,可保護水晶體中其他蛋白及酵素,免於高溫形成凝集。本研究的目的︰則是要進一步探討α-水晶體蛋白結構狀態與分子保護功能的相關性。

在此一研究工作,首先經由cDNA的選殖,我們得到豬的αB-水晶體蛋白的cDNA序列,共有525個鹽基對,相當於175個氨基酸殘基;以此αB基因組轉殖入大腸桿菌,表現出來的蛋白質,可與αB抗血清交叉反應,並具有分子保護作用。

其次,我們發現四大類脊椎動物中,包括哺乳類的牛、鳥類的鴨、爬蟲類的鱷魚、及魚類的鯊魚等,其α-水晶體蛋白的分子保護功能,恰如其初級結構在演化上的保守性,彼此間的差異很小;另外在保護的對象上,亦無受質的專一性。

我們的研究也顯示︰α-水晶體蛋白的分子保護功能,也可以作用於紫外線、氧化及其他壓力下;但是其保護效能較差。部份原因在於α-水晶體蛋白,在紫外線的輻射下會逐漸受到破壞,且破壞的程度與分子保護作用的喪失,呈正相關性。另外人類老年性白內障所得的α-水晶體蛋白,比由正常年輕水晶體的此種蛋白之保護作用變差,這種隨著年齡而減低的功能,可能與眼睛在紫外線的長期暴露有關;同時也說明了α-水晶體蛋白在維持水晶體透明度的重要角色。

α-水晶體蛋白的分子保護作用機制,在於它可與部份變性的蛋白結合成複合物,使其免於進一步的變性。我們將α-水晶體蛋白與其受質短暫加熱,使部份形成複合物,以模擬體內α-水晶體蛋白與β-或γ-水晶體蛋白的結合情形,結果這樣會比單純的分子保護作用對紫外線或氧化等壓力,提供更大的保護;所以在維持水晶體的透明度上,α-水晶體蛋白與其受質的結合,另有更深一層的生理意義。

由圓偏光二色光譜及其他分析,可知α-水晶體蛋白的二級結構主要為β層狀構造。在30℃以上,α-水晶體蛋白會逐漸產生一個不可逆的三級結構變化,並導致其表面疏水性質的提高;這與其分子保護作用的增強,亦呈正相關,顯示疏水性交互作用,在此分子保護作用上的意義。另外在50-70℃,α-水晶體蛋白也會產生一個大部份可逆的二級結構變化,然而後者與其分子保護作用的相關性不大。

總結我們的研究顯示︰α-水晶體蛋白除了傳統的結構蛋白角色外,在維持水晶體透明上,更有極重要的〝管家〞功能;這種功能主要取決於其結構狀態,及其與受質結合之複合物的形成;這些將可提供我們未來在探討白內障的成因與防治上,一個新的思考方向。
ABSTRACT:

Recently, α-crystallin is regarded as a member of small heat shock proteins. Joseph Horwitz also demonstrated in 1992 that it can act as a molecular chaperone to prevent thermal aggregation of other crystallins and enzymes. The main purpose of this thesis is to explore the relationship between the conformational states of α-crystallin and its chaperone activity.

We have first determined the cDNA sequence of αB-crystallin from porcine lenses by cDNA cloning technique. It contains one complete full-length reading frame of 525 base pairs, covering a protein sequence of 175 amino acids. Further expression of this αB subunit chain in E.coli generated a polypeptide which can cross-react with the antiserum against the native αB-crystallin, and also possesses chaperone activity.

The next, a comparative study was conducted to analyze the chaperone activity of α-crystallin from bovine (mammal), duck (bird), caiman (reptile), and shark (fish), respectively. Our results show that the difference in the chaperone activity of α-crystallins among different species is relatively small, indicative of the evolutionary conservation in function similar to that revealed by their conserved protein structure. α-Crystallins of different species also show no substrate specificity in their chaperone activity.

In addition to its anti-heat shock property, α-crystallin can also act as a chaperone against UV-irradiation, H2O2-oxidation, and other stress. However, in terms of stoichiometry, such protective ability is not so efficient as that under thermal stress. Part of the reason is the photochemical susceptibility of α-crystallin to UV-irradiation. The UV-induced destruction was found to correlate with its loss of chaperone activity. Similarly, there is some age-dependent change in the chaperone activity of α-crystallin obtained from a young and normal lens as compared to an old and cataractous lens. Thus, the gradual loss of chaperone activity of α-crystallin upon aging is probably through an accumulative event of long term exposure to UV light, which may also shed light on human cataract formation.

The mechanism underlying the chaperone activity of α-crystallin involves preferential binding of the partially denatured substrate protein to α-crystallin, and the formation of a stable complex. We have demonstrated that the binding of substrate proteins to α-crystallin by short-term pre-incubation may mimic the in vivo conditions of crystallin association. Under such conditions, the chaperone activity of α-crystallin to inhibit ultraviolet-, or oxidation-induced protein aggregation can be greatly enhanced. Thus, the presence ofα-β and α-γ complex in vivo may be relevant to the process of maintaining lens transparency.

From the result of circular dichroism and other studies, it is generally accepted that the secondary structure of α-crystallin consists predominantly of β-sheets. A minor but detectable perturbation in the tertiary structure of α-crystallin occurs at above 30℃, which correlates with the extent of exposure of its hydrophobic surfaces. Such increase in surface hydrophobicity also correlates with its increased chaperone activity. These results indicate that hydrophobic interaction play a major role in the chaperone action of α-crystallin. Another thermotropic transition in the secondary structure of α-crystallin occurs at a range between 50 and 70℃, which is largely reversible. However, the heat-induced changes in secondary structure shows a relatively little effect on the chaperone activity of α-crystallin.

In summary, α-crystallin is not only a major structural protein of the lens but may also play an important "house-keeping" role as a molecular chaperone. Both the conformational state of α-crystallin and the association complex with its substrate may contribute to a generalized mechanism of its chaperone function. Such results may provide us a new direction in the study of cataractogenesis and its treatment in the future.
封面
目錄
略語表
中文摘要
英文摘要
第一章緒論
第二章文獻回顧
第三章材料與方法
第1節α-水晶體蛋白的製備、及西方墨點法
第2節mRNA的製備、cDNA的選殖與定序
第3節αB-水晶體蛋白的表現與製備
第4節α-水晶體蛋白分子保護作用的測定
第5節高效液態層析
第6節螢光分析
第7節圓偏光二色光譜
第四章豬αB-水晶體蛋白的特性、選殖與表現
第五章脊椎動物四大綱之α-水晶體蛋白分子保護作用的比較
第六章α-水晶體蛋白在紫外線破壞下的分子保護作用
第七章α-水晶體蛋白與其受質結合成複合物的生理意義
第八章α-水晶體蛋白立體結構的變化與分子保護作用的相關性
第九章綜合討論與未來展望
第十章圖表
第十一章參考文獻
附錄:修業期間已發表之文獻
參考文獻:

 Abraham EC, Cherian M, Smith JB: Site selectivity in the glycation of αA and αB-crystallins by glucose. Biochem Biophys Res Comm 1994;201:1451-1456.
 Augusteyn RC, Ghiggino KP, Putilina T: Studies on the location of aromatic amino acids in α-crystallin. Biochim Biophys Acta 1993;1162:61-71.
 Benedek GB: Cataract as a protein condensation disease. Invest Ophthalmol Vis Sci 1997;38:1911-1921.
 Benjamin IJ, Shelton J, Farry DJ, et al: Temporospatial expression of the small HSP/αB-crystallin in cardiac and skeletal muscle during mouse development. Dev Dyn 1997;208:75-84.
 Bhat SP, Nagineni CN: αB subunit of lens specific protein α-crystallin is present in other ocular and nonocular tissue. Biochem Biophys Res Commun 1989;158:319-325.
 Bindels JG, Siezen RJ, Hoenders HJ: A model for the architecture of α-crystallin. Ophthalmol Res 1979;11:4410452.
 Bloemendal H (ed): Molecular and cell biology of the eye lens. New York: Wiley; 1981.
 Borkman RF, Knight G, Obi B: The molecular chaperone α-crystallin inhibits UV-induced protein aggregation. Exp Eye Res 1996;62:141-148.
 Bova MP, Fung BKK: The C-terminal region of αA-crystallin is involved in its chaperone function. Invest Ophthalmol Vis Sci 1994;35:S1905.
 Boyle D, Gopalakrishnan S, Takemoto L: Localization of the chaperone binding site. Biochem Biophys Res Comm 1993;192:1147-1154.
 Boyle D, Takemoto L: Characterization of the α-β and α-γ complex: evidence for an in vivo functional role of α-crystallin as a molecular chaperone. Exp Eye Res 1994;58:9-15.
 Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
 Brady JP, Garland D, Duglas-Tabor Y, et al: Targeted disruption of the mouse αA-crystallin gene induced cataract and cytoplasmic inclusion bodies containing the small heat shock protein αB-crystallin. Proc Natl Acad Sci USA 1997;94:884-889.
 Carver JA, Aquilina JA, Truscott RJ: An investigation into the stability of α-crystallin by NMR spectroscopy; evidence for a two-domain structure. Biochim Biophys Acta 1993;1164:22-28.
 Cherian M, Abraham EC: Decreased molecular chaperone property of α-crystallins due to post-translational modifications. Biochem Biophys Res Comm 1995;208:675-679.
 Cherian M, Abraham EC: Diabetes affects α-crystallin chaperone function. Biochem Biophys Res Commun 1995a;212:184-189.
 Chiou SH, Azari P: Physicochemical characterization of α-crystallins from bovine lenses; hydrodynamic and conformational properties. J Protein Chem 1989;8:1-17.
 Chiou SH, Chen SW, Itoh T, Kaji H, Samejima T: Comparison of the γ-crystallins isolated from eye lenses of shark and carp; unique secondary and tertiary structure of shark γ-crystallin. FEBS Lett 1990;275:111-113.
 Chiou SH: Structural characterization of lens crystallins and the perspectives on the evolution and biosynthetic applications of enzymatic crystallins. J Chin Chem Soc 1992;39:721-730.
 Crompton M, Rixon KC, Harding JJ: Aspirin prevents carbamylation of soluble lens proteins and prevent cyanate-induced phase separation opacities in vitro; a possible mechanism by which aspirin could prevent cataract. Exp Eye Res 1985;40:297-311.
 Das BK, Liang JJ, Chakrabarti B: Heat-induced conformational change and increased chaperone activity of lens α-crystallin. Curr Eye Res 1997;16:303-309.
 Das KP, Surwicz WK: Temperature-induced exposure of hydrophobic surfaces and its effect on the chaperone activity of α-crystallin. Febs Lett 1995;369:321-325.
 Dawson CR, Schwet IR: Epidemiology of cataract: a major cause of preventable blindness. Bulletin WHO 1981;59:493-501.
 deJong WW, Terwindt EC, Bloemendal H: The amino acid sequence of the A chain of human α-crystallin. FEBS Lett 1975;58:310-313.
 deJong WW, Zweers A, Versteeg M, et al: Primary structures of the α-crystallin A chains of twenty-eight mammalian species, chicken and frog. Eur J Biochem 1984;141:131-140.
 deJong WW, Leunissen JAM, Hendriks W, et al: Molecular evolution of α-crystallin in quest of a fundtion, in Piatigorsky J, Shinohara T, Zelenka P (eds): Molecular biology of the eye: gene, vision, and ocular diseases. New York, Alan R Liss, 1988, 149-158.
 deJong WW, Hendriks W, Mulders JWM, et al: Evolution of eye lens crystallins; the stress connection. Trends Biochem Sci 1989;14:365-368.
 Delaye M, Clark JI, Benedek GB: Identification of scattering elements responsible for lens opacification in cold cataracts. Biophys J 1982;37:647-656.
 Fung BKK, Bova MP: Mutational analysis of αA-crystallin. Invest Ophthalmol Vis Sci 1997;38:S300.
 Ganea E, Harding JJ: Molecular chaperone protect against glycation-induced inactivation of glucose-6-phosphate dehydrogenase. Eur J Biochem 1995;231:181-185.
 Gesierich U, Pfeil W: The conformational stability of α-crystallin is rather low: colorimetric results. Febs Lett 1996;393:151-154.
 Gething MJ, Sambrook J: Protein folding in the cell. Nature 1992;335:33-45.
 Gopalakrishana S, Boyle D, Takemoto: Preferential interaction of α-crystallin with denatured forms of γ-crystallin. Invest Ophthalmol Vis Sci 1994;35:382-387.
 Groenen PJTA, Merck KB, deJong WW, Bloemendal H: Structure and modifications of the junior chaperone α-crystallin. Eur J Biochem 1994;225:1-19.
 Harding J: Cataract : biochemistry, epidemiology and pharmacology. London: Chapman and Hall; 1991.
 Hogan MJ, Alvarado JA, Weddel JE: Lens, in Histology of the human eye. Philadelphia: WB Saunders; 1971.
 Holl-Neugebauer B, Buchner R: Reconstitution of a heat shock effect on vitro: Influence of Gro E on the thermal aggregation of α-glucosidase from yeast. Biochemistry 1991;30:11609-11614.
 Hook DWA, Harding JJ: α-Crystallin acting as a molecular chaperone protects catalase against steroid-induced inactivation. FEBS Lett 1996;382:281-284.
 Hook DWA, Harding JJ: Molecular chaperone protect catalase against photodamage by UV irradiation. Eur J Biochem 1997;247:380-385.
 Horwitz J: α-Crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA 1992;89:10449-10453.
 Hott JL, Borkman RF: Concentration dependence of transmission loses in UV-laser irradiated bovine α, βH, βL, and γ crystallin solution. Photochem Photobiol 1993;57:312-317.
 Ingolia TD, Craig EA: Four small heat shock proteins are related to each other and to mammalian α-crystallin. Proc Natl Acad Sci USA 1982;79:2360-2364.
 Iwaki T, Kume-Iwaki A, Lie RKH, Goldman JE: αB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander’s disease brain. Cell 1989;57:71-78.
 Kato K, Shinohara H, Kurobe N, et al: Immunoreactive αA-crystallin in rat non-lenticular tissue detected with a sensitive immunoassay system. Biochim Biophys Acta 1991;1080:173-180.
 Kelly MJ, David LL, Iwasaki N, et al: α-Crystallin chaperone activity is reduced by calpain II in vitro and in selenite cataract. J Biol Chem 1993;268:18844-18849.
 Kinoshida JH: Mechanisms initiating cataract formation. Invest Ophthalmol Vis Sci 1974;13:713-724.
 Kramps JA, deMan BM, deJong WW: The primary structure of the B2 chain of human α-crystallin. FEBS Lett 1977;74:82-84.
 Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
Lawson EQ, Schubert CF, Lewis RV, et al: The solubility of bovine lens crystallins. J Biol Chem 1981;256:6523-6525.
 Lee JS, Liang YS, Liao JH, Chiou SH: α-Crystallin from human cataractous lens has chaperone activity to protect other soluble proteins against heat-induced aggregation. Invest Ophthalmol Vis Sci 1996;37:S595.
 Lerman S: Radiant energy and the eye. New York: MacMillan 1980:131-136.
 Li DY, Borkman RF, Wang RH, Dillon J: Mechanisms of photochemically produced turbidity in lens protein solutions. Exp Eye Res 1990;51:663-669.
 Liang JN, Chakrabarti B: Spectroscopic investigations of bovine lens crystallin: circular dichroism and intrinsic fluorescence. Biochemistry 1982;21:1847-1852.
 Lin CW, Chiou SH: Sequence analysis of pigeon δ-crystallin gene and its deduced primary structure; comparison of avian δ-crystallins with and without endogenous argininosuccinate lyase activity. FEBS Lett 1992;311:276-280.
 Litt M, Kramer P, LaMorticella DM, et al: Autosomal dominant congenital cataract associated with a missence mutation in the human α-crystallin gene CRYAA. Hum Mol Genet 1998;7:471-474.
 Lou MF, Dickson Jr JE, Garadi R: The role of protein-thiol mixed disulfides in cataractogenesis. Exp Eye Res 1990;50:819-826.
 Lu SF, Pan FM, Chiou SH: Sequence analysis of frog αB-crystallin cDNA: sequence homology and evolutionary comparison of αA, αB and heat shock protein. Biochem Biophys Res Commun 1995;216:881-891.
 Maiti M, Kono M, Chakrabarti B: Heat-induced changes in the conformation of α- and β-crystallins; unique thermal stability of α-crystallin. FEBS Lett 1988;236:109-114.
 Maniatis T, Fritsh FF, Sambrook J: In Molecular Cloning: a laboratory manual. Cold Spring, Harbor Press. New York 1989.
 Marini I, Bucchioni L, Voltarelli M, et al: α-Crystallin —like molecular chaperone against the thermal denaturation of lens aldose reductase; the effect of divalent metal ions. Biochem Biophys Res Commun 1995;212:413-420.
 McFall-NGAI MJ, Horwitz J: Comparative study of the thermal stability of the vertebrate eye lens; antarctic ice fice to the desert inguana. Exp Eye Res 1990;50:703-709.
 Morner CT: Untersuchung der protein substanzen in den leichtbrechenden medien des auges, Hoppe Seyler’s Z. Physiol Chem 1984;18:61-106.
 Muchowski PJ, Clark JI: ATP-enhanced molecular chaperone functions of the small heat shock protein human αB-crystallin. Proc Natl Acad Sci USA 1998;95:1004-1009.
 Nilsson B, Anderson S: Proper and improper folding of proteins in the cellular enviroment. Annu Rec Microbiol 1991;45:607-635.
 O’Day DM: The cataract management guideline panel of the agency for health care policy and research. Management of cataract in adults. Quick reference guide for clinicians. Arch Ophthalmol 1993;111:453-459.
 Parkhurst CA, Pande AK: α-Crystallin modulates the phase-separation temperature of γ-crystallin solutions. Invest Ophthalmol Vis Sci 1994;35:S2212.
 Piatigorsky J, Wistow GJ: Gene sharing as an evolutionary strategy. Cell 1989;57:197-199.
 Plater ML, Goode D, Crabbe MJC: Effect of site-directed mutations on the chaperone-like activity of αB-crystallin. J Biol Chem 1996;271:28558-28566.
 Plater ML, Goode D, Crabbe MJ: Ibuprofen protects α-crystallin against posttranslational modification by preventing protein cross-linking. Ophthalmic Res 1997;29:421-428.
 Raman B, Rao M: Chaperone-like activity and the quaternary structure of α-crystallin. J Biol Chem 1994;269:27264-27268.
 Rao PV, Horwitz J, Ziegler Jr JS: α-Crystallin, a molecular chaperone, forms a stable complex with carbonic anhydrase upon heat denaturation. Biochem Biophys Res Comm 1993;190:786-793.
 Rao PV, Huang QL, Horwitz J, et al: Evidence that α-crystallin prevents non-specific protein aggregation in the intact eye lens. Biochim Biophys Acta 1995;1245:439-447.
 Renkawek K, deJong WW, Merck KB, et al: αB-Crystallin is present in reactive glia in Creutzfeldt-Jakob disease. Acta Neuropathol 1992;83:324-327.
 Sax CM, Piatigorsky J: Expression of the α-crystallin/small heat-shock protein/molecular chaperone genes in the lens and other tissues. Adv Enzymol Relat Areas Mol Biol 1994;69:155-201.
 Schauerte JA, Gafni A: Photodegradation of tryptophan residues and attenuation of molecular chaperone activity in α-crystallin are correlated. Biochem Biophys Res Comm 1995;212:900-905.
 Sharma KK, Kaur H, Kester K: Functional elements in molecular chaperone α-crystallin; identification of binding sites in αB-crystallin. Biochem Biophys Res Commun 1997;9:217-222.
 Siebert PD, Chenchik A, Kelligg DE, et al: An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res 1995;23:1087-1088.
 Siezen RJ, Coppin CM, Benedeck GB: Permanent suppression of phase separation cataract in calf lens using amine modification agents. Biochem Biophys Res Commun 1985;133:239-247.
 Smulders RH, Merck KB, Aendekerk J, et al: The mutation Asp69->Ser affects the chaperone-like activity of αA-crystallin. Eur J Biochem 1995;232:834-838.
 Spector A, Garner WH: Hydrogen peroxide and human cataract. Exp Eye Res 1981;33:673-681.
 Spector A: Aspects of the biochemistry of cataract, in Maised H (ed): The ocular lens. New York: Marcel Dekker; 1985:405-433.
 Stapel SO, Leunissen JAM, Versteeg M, et al: Ratities as oldest offshoot of avian stem — evidence from α-crystallin A sequences. Nature 1984;311:257-259.
 Steinberg EP, Javitt JC, Sharkey PD, et al: The content and cost of cataract surgery. Arch Ophthamol 1993;111:1041-1049.
 Steves A, Augusteyn RC: Binding of 1-anilinonaphthalene-8-sulfonic and to α-crystallin. Eur J Biochem 1997;243:792-797.
Subramanian G, Takemoto LJ: Localization of the actin binding region of α-crystallin. Invest Ophthalmol Vis Sci 1994;35:S2212.
 Sun TX, Das BK, Liang JJN: Conformational and functional differences between recombinant human lens αA and αB crystallin. J Biol Chem 1997;272:6220-6225.
 Sun TX, Liang JJN: Intermolecular exchange and stabilization of recombinant human αA and αB crystallin. J Biol Chem 1998;273:286-290.
 Surewicz WK, Olesen PR: On the thermal stability of α-crystallin: a new insight from infrared spectroscopy. Biochemistry 1995;34:9655-9660.
 Takemoto L, Horwitz J, Emmons T: Oxidation of the N-terminal methionine of lens αA-crystallin. Curr Eye Res 1992;7:651-655.
 Takemoto L, Boyle D: Molecular chaperone properties of the high molecular weight aggregate from aged lens. Curr Eye Res 1994;13:35-44.
 Takemoto L, Boyle D: Binding of denatured protein decreases the chaperone properties of α-crystallin. Arch Biochem Biophys 1994a;315:133-136.
 Tamm ER, Russell P, Johnson DH, et al: Human and monkey trabecular meshwork accumulate αB-crystallin in response to heat shock and oxidative stress. Invest Ophthalmol Vis Sci 1996;37:2402-2413.
 Tanaka T, Ishimoto C, Chylack LT Jr: Phase seperation of a protein-water mixture in cold cataract in the young rat lens. Science 1977;197:1010-11012.
 Tardieu A, Laporte D, Licinio P, et al: Calf lens α-crystallin quaternary structure: a three-layer tetrahedral model. J Mol Biol 1986;192:711-724.
 van-den-IJssel PR, Overkamp P, Knauf U, et al: αA-crystallin confers cellular thermoresistance. FEBS Lett 1994;355:54-56.
 Walsh MT, Sen AC, Chakrabarte B: Micellar subunit assembly in a three-layer of oligomeric α-crystallin. J Biol Chem 1991;266:20079-20084.
 Wang K, Spector A: The chaperone activity of bovine α-crystallin; interaction with other lens crystallins in native and denatured states. J Biol Chem 1994;269:13601-13608.
 Wang K, Spector A: α-Crystallin can act as a chaperone under conditions of oxidative stress. Invest Ophthalmol Vis Sci 1995;36:311-321.
 Wistow GJ, Piatigorsky J: Recruitment of enzymes as lens structural proteins. Science 1987;236:1554-1556.
 Wistow GJ, Lietman T, Williams LA: τ-Crystallin/α-enolase: one gene encode both an enzyme and a lens structural protein. J Cell Biol 1988;107:2729-2736.
 Wistow GJ, Piatigorsky: Lens crystallins: the evolution of proteins for a highly specialized tissue. Ann. Rev Biochem 1988(a);57:479-504.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
1. 19.黃國師,「庫藏股制度的會計處理」,實用稅務,第309期,民國八十九年九月,23∼28頁。
2. 7.林國德,「庫藏股票對股票的影響」,統領雜誌,第149期,民國八十六年十二月,48∼49頁。
3. 18.郭土木,「證交法庫藏股制度之探討」,實用稅務,第309期,民國八十九年九月,13∼21頁。
4. 26.劉連煜,「庫藏股制度評析」,實用稅務,第281期,民國八十七年五月,62∼71頁。
5. 4.吳崇權,「推動庫藏股票制度之立法」,證券暨期貨管理,第16:10期,民國八十七年十月,34∼36頁。
6. 17.商景明、臧仕維,「多空論戰:變調的庫藏股制度」,實用稅務,第308期,民國八十九年八月,85∼91頁。
7. 2.吳正治,「庫藏股制度的利多與利空」,錢雜誌,第134期,民國八十六年十二月,76∼80頁。
8. 25.劉玉珍、高惠娟,「淺談庫藏股票制度」,證券暨期貨管理,第16:4期,民國八十七年四月,1∼12頁。
9. 23.廖大穎,「庫藏股制度與證券交易」,月旦法學,第34期,民國八十七年三月,90∼97頁。
10. 16.陳貴端,「我國擬議中庫藏股制度之評析」,財稅研究,第32卷,第1期,民國八十九年一月,80∼86頁。
11. 11.邱秋芳,「庫藏股制度的利弊得失」,實用稅務,民國八十九年九月,7∼11頁。
12. 22.馮震宇,「庫藏股是解決交叉持股的良方﹖」,能力雜誌,第515期,民國八十八年一月,92∼99頁。
13. 21.曾素貞,「庫藏股制度介紹」,產業經濟,第197期,民國八十七年一月,1∼4頁。彭嘉儀,「庫藏股為誰解套﹖」,卓越雜誌,第171期,民國八十七年十一月,86∼88頁。
14. 20.張育寧,「公司可買回在外的股票--庫藏股有助於資本市場發展」,遠見雜誌,第171期,民國八十九年九月,234∼240頁。
15. 9.林進富,「我國庫藏股制度之評議」,實用稅務,第289期,民國八十八年一月,82∼85頁。